Healthcare Equipment and Supplies
Company Overview of Amedica Corporation
Amedica Corporation, a commercial-stage biomaterial company, develops, manufactures, and sells a range of medical devices based on its silicon nitride ceramic technology platform in the United States, Europe, and South America. The company offers Valeo silicon nitride spinal fusion devices for use in the cervical and thoracolumbar areas of the spine; and a line of non-silicon nitride spinal surgery products for the treatment of deformity and degenerative spinal procedures. It also develops femoral heads for use in total hip replacements; and femoral condyle components for use in total knee replacements. The company markets and sells its products to surgeons and hospitals directly, as well as...
1885 West 2100 South
Salt Lake City, UT 84119
Founded in 1996
Key Executives for Amedica Corporation
Chairman of the Board, Chief Executive Officer, President and Principal Financial Officer
Total Annual Compensation: $409.6K
Chief Technology Officer
Total Annual Compensation: $257.4K
Compensation as of Fiscal Year 2015.
Amedica Corporation Key Developments
Amedica Corporation Announces Workforce Reduction
Oct 5 16
Amedica Corporation announced that it has reduced its workforce by approximately 38% to lower its operating expenses. The company will continue to focus on its commercial sales strategy to add new surgeons, territories, and distributors. The actions associated with the plan were implemented on October 3, 2016 and completed on October 4, 2016. The company estimates the staff reductions to result in savings of approximately $2.0 million in cash operating expenses on an annualized basis, with estimated one-time severance and related costs related to the restructuring of approximately $0.465 million expected to be recorded in the fourth quarter of 2016.
Amedica Corporation Presents at Ladenburg Thalmann 2nd Annual Healthcare Conference, Sep-27-2016 10:00 AM
Sep 1 16
Amedica Corporation Presents at Ladenburg Thalmann 2nd Annual Healthcare Conference, Sep-27-2016 10:00 AM. Venue: The Sofitel New York, New York, New York, United States.
Amedica Corporation Receives FDA Clearance for Additional Valeo II Lateral Lumbar Interbody Fusion Device Offerings
Aug 24 16
Amedica Corporation announced the U.S. Food and Drug Administration (FDA) clearance of expanded Valeo II Lateral Lumbar sizes. The additional sizes of the Valeo II LL interbody fusion device will be commercially available August 29, 2016. The Valeo II LL interbody fusion device is made entirely of Amedica's proprietary medical grade silicon nitride ceramic - an ideal material for fusion, due to its inherent osteoconductivity, anti-infective properties, bone-like imaging (artifact-free &radiotranslucent), and exceptional strength. The system includes second generation instrumentation to improve patient safety and surgeon ease of use. The recently cleared sizes allow for greater accommodation for a wide range of patient anatomies as well as greater stability as the shape of the implant distributes weight over a larger surface area. The design of the interbody fusion device consists of aggressive teeth for expulsion resistance, knurls for added stability, a threaded insertion feature for precision implant control, and two central cavities maximized for optimal bone graft packing.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|